2016
DOI: 10.1128/mcb.00130-16
|View full text |Cite
|
Sign up to set email alerts
|

Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications

Abstract: Aberrant activation of the Wnt/␤-catenin pathway and polo-like kinase 1 (Plk1) overexpression represent two common events in prostate cancer with relevant functional implications. This minireview analyzes their potential therapeutic significance in prostate cancer based on their role as androgen receptor (AR) signaling regulators and the pivotal role of the tumor suppressor protein phosphatase 2A (PP2A) modulating these pathways.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 106 publications
0
14
0
Order By: Relevance
“…and inhibition of PP2A activity . CIP2A controls autophagy and cell growth through mTORC1 activation, synergizes with RAS, and crosstalks with Wnt/β‐catenin signal pathway to promote cell proliferation and cancer progression . It also mediates interleukin 10 (IL‐10)‐induced tumour aggressiveness .…”
Section: Introductionmentioning
confidence: 99%
“…and inhibition of PP2A activity . CIP2A controls autophagy and cell growth through mTORC1 activation, synergizes with RAS, and crosstalks with Wnt/β‐catenin signal pathway to promote cell proliferation and cancer progression . It also mediates interleukin 10 (IL‐10)‐induced tumour aggressiveness .…”
Section: Introductionmentioning
confidence: 99%
“…Similarly an alteration of Wnt signalling after the down regulation of PLK1 could also account for observed therapeutic effect in RB cells. An increased PLK1 expression modulated Wnt signalling pathway was identified in prostate cancer 26 .…”
Section: Discussionmentioning
confidence: 99%
“…Due to the involvement of Wnt/β‐catenin pathway in progression, it has been suggested to act as a molecular marker for predicting resistance to several androgen‐dependent therapies . Due to their important role in tumorigenesis and metastasis, genes involved in canonical and non‐canonical Wnt signaling pathways are emerging as promising targets for therapeutic intervention in PCa . Future studies are needed to not only understand the mechanism of Wnt signaling driven PCa but also identify race‐specific therapeutic potential.…”
Section: Discussionmentioning
confidence: 99%